Well - of course it could go either way however on balance I thought it was worth the risk today.
Surely if it works as advertised this company is worth multiples of where we are today.
In it for the long term for these reasons:
Investment Highlights
NOVEL ANTIVIRAL PLATFORM
Targeting viroporin proteins with a rapid screening proprietary primary bacterial cell-based platform - a library of over 350 compounds with activity against a range of viruses.
BROAD ANTIVIRAL PIPELINE
Clinical and Preclinical programs in indications with high unmet clinical need or large patient populations such as HIV-1, HCV & Dengue, HBV, Zika & Influenza.
ROBUST CLINICAL VALIDATION
Completed 7 human Clinical Trials with promising safety and efficacy outcomes.
STRONG INTELLECTUAL PROPERTY POSITION
Portfolio of patents and patent applicaTons directed to the Company’s anti-viral drug portfolio.
GLTAH
$1.00 On The Horizon, page-381
-
- There are more pages in this discussion • 505 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
-0.003(9.09%) |
Mkt cap ! $27.06M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.4¢ | 3.0¢ | $32.26K | 1.016M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 720804 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |